Characteristics of Patients With Initial Positive vs Negative Test in the Long-term Effectiveness Analysis
| Characteristic . | Initial Positive Test . | Initial Negative Test . | |
|---|---|---|---|
| Number of patients | 11 186 | 141 470 | |
| Age ± SD, years | 50.5 ± 21.0 | 52.8 ± 21.4 | |
| Sex female (%) | 5900 (52.7) | 79 975 (56.5) | |
| Number who were retested (%) | 2187 (19.6) | 47 539 (33.6) | |
| Age ± SD, years | 52.9 ± 21.2 | 54.0 ± 21.3 | |
| Sex female (%) | 1252 (57.2) | 27 471 (57.8) | |
| Retest positive, any (%) | 81 (0.7) | 7167 (5.1) | |
| Time to positive retest ± SD, days | 181.6 ± 106.8 | 223.3 ± 93.3 | |
| Retest positive, symptomatic (%) | 38 (0.3) | 6030 (4.3) | |
| Any Infection, % | Symptomatic Infection, % | Asymptomatic Infection, % | |
| Effectiveness, days | 85.7 | 92.0 | 52.2 |
| 90–150 | 63.9 | 82.9 | –34.6 |
| 151–210 | 93.2 | 96.0 | 77.9 |
| 211–270 | 93.9 | 96.3 | 79.8 |
| 271–330 | 91.3 | 91.6 | 89.7 |
| 331–390 | 90.8 | 88.9 | 100 |
| After 390 | 87.3 | 95.0 | 44.0 |
| Characteristic . | Initial Positive Test . | Initial Negative Test . | |
|---|---|---|---|
| Number of patients | 11 186 | 141 470 | |
| Age ± SD, years | 50.5 ± 21.0 | 52.8 ± 21.4 | |
| Sex female (%) | 5900 (52.7) | 79 975 (56.5) | |
| Number who were retested (%) | 2187 (19.6) | 47 539 (33.6) | |
| Age ± SD, years | 52.9 ± 21.2 | 54.0 ± 21.3 | |
| Sex female (%) | 1252 (57.2) | 27 471 (57.8) | |
| Retest positive, any (%) | 81 (0.7) | 7167 (5.1) | |
| Time to positive retest ± SD, days | 181.6 ± 106.8 | 223.3 ± 93.3 | |
| Retest positive, symptomatic (%) | 38 (0.3) | 6030 (4.3) | |
| Any Infection, % | Symptomatic Infection, % | Asymptomatic Infection, % | |
| Effectiveness, days | 85.7 | 92.0 | 52.2 |
| 90–150 | 63.9 | 82.9 | –34.6 |
| 151–210 | 93.2 | 96.0 | 77.9 |
| 211–270 | 93.9 | 96.3 | 79.8 |
| 271–330 | 91.3 | 91.6 | 89.7 |
| 331–390 | 90.8 | 88.9 | 100 |
| After 390 | 87.3 | 95.0 | 44.0 |
Abbreviation: SD, standard deviation.
Characteristics of Patients With Initial Positive vs Negative Test in the Long-term Effectiveness Analysis
| Characteristic . | Initial Positive Test . | Initial Negative Test . | |
|---|---|---|---|
| Number of patients | 11 186 | 141 470 | |
| Age ± SD, years | 50.5 ± 21.0 | 52.8 ± 21.4 | |
| Sex female (%) | 5900 (52.7) | 79 975 (56.5) | |
| Number who were retested (%) | 2187 (19.6) | 47 539 (33.6) | |
| Age ± SD, years | 52.9 ± 21.2 | 54.0 ± 21.3 | |
| Sex female (%) | 1252 (57.2) | 27 471 (57.8) | |
| Retest positive, any (%) | 81 (0.7) | 7167 (5.1) | |
| Time to positive retest ± SD, days | 181.6 ± 106.8 | 223.3 ± 93.3 | |
| Retest positive, symptomatic (%) | 38 (0.3) | 6030 (4.3) | |
| Any Infection, % | Symptomatic Infection, % | Asymptomatic Infection, % | |
| Effectiveness, days | 85.7 | 92.0 | 52.2 |
| 90–150 | 63.9 | 82.9 | –34.6 |
| 151–210 | 93.2 | 96.0 | 77.9 |
| 211–270 | 93.9 | 96.3 | 79.8 |
| 271–330 | 91.3 | 91.6 | 89.7 |
| 331–390 | 90.8 | 88.9 | 100 |
| After 390 | 87.3 | 95.0 | 44.0 |
| Characteristic . | Initial Positive Test . | Initial Negative Test . | |
|---|---|---|---|
| Number of patients | 11 186 | 141 470 | |
| Age ± SD, years | 50.5 ± 21.0 | 52.8 ± 21.4 | |
| Sex female (%) | 5900 (52.7) | 79 975 (56.5) | |
| Number who were retested (%) | 2187 (19.6) | 47 539 (33.6) | |
| Age ± SD, years | 52.9 ± 21.2 | 54.0 ± 21.3 | |
| Sex female (%) | 1252 (57.2) | 27 471 (57.8) | |
| Retest positive, any (%) | 81 (0.7) | 7167 (5.1) | |
| Time to positive retest ± SD, days | 181.6 ± 106.8 | 223.3 ± 93.3 | |
| Retest positive, symptomatic (%) | 38 (0.3) | 6030 (4.3) | |
| Any Infection, % | Symptomatic Infection, % | Asymptomatic Infection, % | |
| Effectiveness, days | 85.7 | 92.0 | 52.2 |
| 90–150 | 63.9 | 82.9 | –34.6 |
| 151–210 | 93.2 | 96.0 | 77.9 |
| 211–270 | 93.9 | 96.3 | 79.8 |
| 271–330 | 91.3 | 91.6 | 89.7 |
| 331–390 | 90.8 | 88.9 | 100 |
| After 390 | 87.3 | 95.0 | 44.0 |
Abbreviation: SD, standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
